Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Lancet Neurol. 2014 May 27;13(7):676–685. doi: 10.1016/S1474-4422(14)70088-2

Figure 2. Change from baseline in primary outcome measures, the PSPRS and SEADL.

Figure 2

(A) Least squares mean ± SEM change from baseline in PSPRS from primary ITT analysis. P = 0.41. An increase in PSPRS indicates worse disease.

(B) Least squares mean ± SEM change from baseine in SEADL from primary ITT analysis. P = 0.92. A decrease in SEADL indicates worse performance.